Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > J Korean Cancer Assoc > Volume 26(3); 1994 > Article
Original Article
Comparison of Serum Prostate Specific Antigen and Pathologic Findings on Patient with Benign Prostatic Hyperplasia
Sung Goo Chang, Chur Chill Sin, Choong Hyun Lee, Ju Hie Lee, Soo Eung Chai
Journal of the Korean Cancer Association 1994;26(3): 474-484.
  • 2,161 Views
  • 13 Download
  • 0 Crossref
  • 0 Scopus
prev next

Prostate specific antigen(PSA) is a serine protease produced by both benign and malignant prostatic epithelium that can be measured in serum samples by immuoassay. Although recent studies suggest that serum PSA may be useful in the early detection of prostate cancer, it is known that PSA elevations occur in men with benign prostatic hyperplasia and that men with prostate cancer can have normal PSA leveL We evaluated serum prostate specific antigen and pathologic findings on patient with benign prostatic hyperplasia. The most significant factor affecting high serum PSA levels in patient with B.P.H. was P.I.N. Identification of PIN will be helpful to detect early prostatic cancer because PIN is consid- ered a precursor of prostatic cancer.

  • Cite
    CITE
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Comparison of Serum Prostate Specific Antigen and Pathologic Findings on Patient with Benign Prostatic Hyperplasia
    J Korean Cancer Assoc. 1994;26(3):474-484.
    Close

Cancer Res Treat : Journal of the Korean Cancer Association
Close layer
TOP